North Korea vs Late-demographic dividend: Immunization, HepB3 (% of one-year-old children)
Immunization, HepB3 (% of one-year-old children) over time
- North Korea
- Late-demographic dividend
How they compare
North Korea currently reports 99.0% against 94.0% in Late-demographic dividend, a difference of 5.0%.
That makes North Korea's figure about 1.1 times Late-demographic dividend's.
The two have swapped places 3 times across 22 shared years of data; in 2003 it was Late-demographic dividend ahead.
North Korea ranks 1st and Late-demographic dividend ranks 3rd of 188 countries.
Across the 3 decades both report, North Korea averaged higher in 1 and Late-demographic dividend in 2.
Head to head by decade
| Decade | North Korea | Late-demographic dividend | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 84.3% | 89.8% | 5.5% | Late-demographic dividend |
| 2010s | 95.2% | 96.7% | 1.5% | Late-demographic dividend |
| 2020s | 98.6% | 93.5% | 5.1% | North Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, North Korea or Late-demographic dividend?
- North Korea, at 99.0% against 94.0% in Late-demographic dividend as of 2024.
- What is the difference in immunization, hepb3 between North Korea and Late-demographic dividend?
- 5.0%, with North Korea ahead.
- How many years of comparable data are there for North Korea and Late-demographic dividend?
- 22 years are reported by both, from 2003 to 2024.
- How do North Korea and Late-demographic dividend rank globally for immunization, hepb3?
- North Korea ranks 1st and Late-demographic dividend ranks 3rd of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.